Boston Scientific Corp
(MIL:1BSX)
€
85.5
0 (0%)
Market Cap: 126.98 Bil
Enterprise Value: 135.61 Bil
PE Ratio: 74.26
PB Ratio: 6.39
GF Score: 56/100 Boston Scientific Corp at Canaccord Genuity Growth Conference Transcript
Aug 08, 2019 / 02:00PM GMT
Jason Richard Mills
Canaccord Genuity Corp., Research Division - MD of Research & Analyst
Hi, good morning. Maybe get started as people file in so that we can get in as many questions here with Boston Scientific. Very happy to have Boston Scientific, a local company but certainly a global company, at the Canaccord conference. Again, I'm Jason Mills, senior medical devices analyst. Very happy to have the Head of Investor Relations, Susie Lisa; and also Lauren as well with her to talk about the business. Thank you very much for coming.
Susan Vissers Lisa
Boston Scientific Corporation - VP of IR
Thanks for having us. Yes.
Jason Richard Mills
Canaccord Genuity Corp., Research Division - MD of Research & Analyst
And hopefully, this is a productive meeting for you guys as well as you tell your story.
Questions & Answers
Jason Richard Mills
Canaccord Genuity Corp., Research Division - MD of Research & Analyst
Recent news, let's just start there and
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot